Live Breaking News & Updates on Alimera Sciences Company Profile

Stay updated with breaking news from Alimera sciences company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Alimera Sciences, Inc. (NASDAQ:ALIM) Short Interest Update

Alimera Sciences, Inc. (NASDAQ:ALIM – Get Free Report) was the recipient of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 103,900 shares, a decline of 14.6% from the April 30th total of 121,700 shares. Based on an average daily trading volume, of 67,700 […] ....

United States , Vanguard Group Inc , Worth Venture Partners , Hillsdale Investment Management Inc , Hedge Funds Weigh In On Alimera Sciences , Alimera Sciences Inc , Maxim Group , Alimera Sciences Stock Down , Ancora Advisors , News Ratings For Alimera Sciences Daily , Alimera Sciences , Alimera Sciences Company Profile , Get Free Report , Lane Capital , Investment Management , Venture Partners , Vanguard Group , Sciences Stock Down , Operating Cost , Alimera Sciences Daily ,

Alimera Sciences' (ALIM) Buy Rating Reaffirmed at HC Wainwright

Alimera Sciences' (ALIM) Buy Rating Reaffirmed at HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Vanguard Group Inc , Alimera Sciences Company Profile , Worth Venture Partners , Alimera Sciences , Hillsdale Investment Management Inc , Alimera Sciences Inc , Alimera Sciences Price Performance , News Ratings For Alimera Sciences Daily , Institutional Trading Of Alimera Sciences , Maxim Group , Ancora Advisors , Free Report , Get Free Report , Lane Capital , Investment Management , Venture Partners , Vanguard Group , Operating Cost , Alimera Sciences Daily ,

Alimera Sciences (NASDAQ:ALIM) Downgraded by StockNews.com to Hold

StockNews.com lowered shares of Alimera Sciences (NASDAQ:ALIM – Free Report) from a buy rating to a hold rating in a report published on Tuesday morning. Separately, Maxim Group assumed coverage on Alimera Sciences in a report on Monday, March 25th. They set a buy rating and a $10.00 target price on the stock. View Our […] ....

United States , Stonepine Capital Management , Alimera Sciences Company Profile , Alimera Sciences Stock , Maxim Group , News Ratings For Alimera Sciences Daily , Capital Management , Worth Venture Partners , Alimera Sciences , Alimera Sciences Inc , Free Report , Get Free Report , Venture Partners , Fifth Lane Capital , Operating Cost , Alimera Sciences Daily , Nasdaq Alim , Stocknews Com ,

StockNews.com Lowers Alimera Sciences (NASDAQ:ALIM) to Hold

StockNews.com downgraded shares of Alimera Sciences (NASDAQ:ALIM – Free Report) from a buy rating to a hold rating in a research note issued to investors on Tuesday morning. Separately, Maxim Group started coverage on shares of Alimera Sciences in a research report on Monday, March 25th. They set a buy rating and a $10.00 price […] ....

United States , Maxim Group , Alimera Sciences Company Profile , Stonepine Capital Management , Alimera Sciences Stock Performance , Alimera Sciences Inc , Alimera Sciences , Hedge Funds Weigh In On Alimera Sciences , Worth Venture Partners , Capital Management , News Ratings For Alimera Sciences Daily , Free Report , Get Free Report , Venture Partners , Fifth Lane Capital , Operating Cost , Alimera Sciences Daily , Nasdaq Alim , Stocknews Com ,

StockNews.com Lowers Alimera Sciences (NASDAQ:ALIM) to Hold

StockNews.com Lowers Alimera Sciences (NASDAQ:ALIM) to Hold
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Alimera Sciences Company Profile , Capital Management , Alimera Sciences , Stonepine Capital Management , Alimera Sciences Trading , Alimera Sciences Inc , News Ratings For Alimera Sciences Daily , Maxim Group , Worth Venture Partners , Free Report , Get Free Report , Venture Partners , Fifth Lane Capital , Operating Cost , Alimera Sciences Daily ,